EUVIMEDEUVIMED entdecken
Multizentrische Studie

Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer

Guilherme Nader-Marta iD, Yue Zheng iD, Shoshana M Rosenberg, Kate E Dibble iD, Erica L Mayer iD, Philip D Poorvu iD, Kathryn J Ruddy iD, Yaileen D Guzman-Arocho, Laura C Collins, Jeffrey Peppercorn iD, Lidia Schapira, Carmine Valenza iD und 7 weitere

JNCI: Journal of the National Cancer Institute · 2026

DOI: 10.1093/jnci/djag152 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2026. Verfasst von Guilherme Nader-Marta und 18 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Pregnancy Complications, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Breast Cancer Research Foundation, American Cancer Society Research Professorship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) diagnosed during pregnancy or postpartum often presents with aggressive features, potentially influenced by hormonal, immunological, and tissue remodeling changes. Studies have suggested that postpartum BC may be associated with worse outcomes, though most evidence is retrospective and constrained by methodological limitations. This study evaluated associations between pregnancy history, recency of childbirth, and long-term outcomes in a prospective cohort of young patients with early-stage BC. Patients and Methods Patients aged ≤40 years with stage I–III BC enrolled in the Young Women’s Breast Cancer Study were categorized at diagnosis as nulligravid, nulliparous, pregnant, or parous (≤5 vs 5 to 10 years postpartum). Analyses were stratified by BC subtype (estrogen receptor-positive [ER+]/HER2−, HER2+, and triple-negative [TNBC]), with distant recurrence-free survival (DRFS) as the primary endpoint.

Results

Among 859 patients, 257 (29.9%) were nulligravid, 50 (5.8%) nulliparous, 37 (4.3%) pregnant, and 515 (60.0%) parous. Pregnant patients had proportionally more TNBC, nodal involvement, T3/T4, and grade 3 tumors. After 11.1 years median follow-up, pregnancy or postpartum status was not independently associated with DRFS in multivariable models adjusted for age, tumor characteristics, and treatment, with consistent findings across ER+/HER2−, HER2+, and TNBC subtypes. Sensitivity analyses, including further categorization of postpartum diagnoses (<2 vs 2 to 5 years), yielded consistent results.

Conclusions

Pregnancy history and recency of childbirth were not independently associated with long-term DRFS. Despite more aggressive features at diagnosis, patients diagnosed during or after pregnancy had comparable outcomes after adjustment, suggesting no adverse prognostic impact. Clinical trial registration NCT01468246 (https://clinicaltrials.gov/study/NCT01468246? term=NCT01468246&rank=1).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPregnancy Complications, NeoplasticAdultFemaleHumansPregnancyYoung AdultDisease-Free SurvivalErb-b2 Receptor Tyrosine KinasesNeoplasm Recurrence, LocalNeoplasm StagingParityParturitionPostpartum PeriodProspective StudiesReceptors, EstrogenTriple Negative Breast NeoplasmsCohort Studies

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, Estrogen

Autor:innen und Institutionen

  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
  • Harvard Medical School, Boston, MA, United States.
  • Data Science, Dana-Farber Cancer Institute, Boston, MA, United States.
  • Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
  • Medical Oncology, Mayo Clinic, Rochester, MN, United States.
  • Pathology, Beth Israel Deaconess Medical Center, Boston, MA, United States.

ORCID-Profile: Guilherme Nader-Marta, Yue Zheng, Kate E Dibble, Erica L Mayer, Philip D Poorvu, Kathryn J Ruddy, Jeffrey Peppercorn, Carmine Valenza, Nabihah Tayob, Kornelia Polyak, Ann H Partridge

Förderung

  • Breast Cancer Research Foundation
  • American Cancer Society Research Professorship

Zitieren

APA

Nader-Marta, G., Zheng, Y., Rosenberg, S. M., Dibble, K. E., Mayer, E. L., Poorvu, P. D., Ruddy, K. J., Guzman-Arocho, Y. D., Collins, L. C., Peppercorn, J., Schapira, L., Valenza, C., Borges, V. F., Tayob, N., Come, S. E., Warner, E., Polyak, K., Winer, E. P., & Partridge, A. H. (2026). Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag152

Vancouver

Nader-Marta G, Zheng Y, Rosenberg SM, Dibble KE, Mayer EL, Poorvu PD, et al. Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer. JNCI: Journal of the National Cancer Institute. 2026. doi:10.1093/jnci/djag152

BibTeX
@article{NaderMarta2026,
  author = {Nader-Marta, Guilherme and Zheng, Yue and Rosenberg, Shoshana M and Dibble, Kate E and Mayer, Erica L and Poorvu, Philip D and Ruddy, Kathryn J and Guzman-Arocho, Yaileen D and Collins, Laura C and Peppercorn, Jeffrey and Schapira, Lidia and Valenza, Carmine and Borges, Virginia F and Tayob, Nabihah and Come, Steven E and Warner, Ellen and Polyak, Kornelia and Winer, Eric P and Partridge, Ann H},
  title = {Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2026},
  doi = {10.1093/jnci/djag152}
}
Kostenlos starten →